.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,258,830

« Back to Dashboard

Summary for Patent: 6,258,830

Title: Stable gel formulation for topical treatment of skin conditions
Abstract:The present invention provides a stable gel formulation for topical treatment of skin conditions in humans. The stable gel formulation includes an active agent, having activity for treatment of acne and psoriasis, which is insoluble in water and a plurality of nonaqueous vehicles for both solubilizing said active agent and forming a gel therewith enabling topical application of the gel to a skin condition. The plurality of vehicles are each present in amounts, and in combination, to control release of the active agent from-the gel to the skin condition.
Inventor(s): Charu; Prakash M. (Fullerton, CA)
Assignee: Allergan Sales, Inc. (Irvine, CA)
Application Number:09/260,217
Patent Claim Types:
see list of patent claims
Use; Formulation;
Patent Metrics:
Source: PatentQuant.com
Field: Not categorized
Back Citations: 8th percentile
Forward Citations: 0th percentile
Patent PDF download available with subscription

No matches for this query

International Patent Family for Patent: 6,258,830

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria215836<disabled in preview>
Austria336263<disabled in preview>
Australia2821895<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc